Adel K El-Naggar

8PUBLICATIONS
58CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityPredictive and prognostic markersSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 13, 2026
Axitinib plus Avelumab in Recurrent/Metastatic Adenoid Cystic Carcinoma: Biomarker Analysis and Updated Results of the Phase II Trial.

Camilla O Hoff, Simon Heeke, Yoshitsugu Mitani

|Feb 19, 2026
Sustained Response to Lorlatinib and Pemetrexed in ALK Fusion-Positive Anaplastic Thyroid Carcinoma With Multiple Distant Metastases: A Case Report.

Matheus Sewastjanow-Silva, Maria E Cabanillas, Eduardo Andreazza Dal Lago

|Dec 01, 2025
Lithium Therapy-Associated Thyroid Alterations Mimicking Thyroid Malignancy: A Diagnostic Pitfall.

Irene Y Chen, Adel K El-Naggar

|Nov 12, 2024
Phase II Trial of Induction Chemotherapy for Advanced Sinonasal Squamous Cell Carcinoma.

Kevin J Contrera, Renata Ferrarotto, Brandon Gunn

|Jul 12, 2024
p53R172H and p53R245W Hotspot Mutations Drive Distinct Transcriptomes in Mouse Mammary Tumors Through a Convergent Transcriptional Mediator.

Joy M McDaniel, Rhiannon L Morrissey, Denada Dibra

|May 31, 2023
Spatial Immunoprofiling of Adenoid Cystic Carcinoma Reveals B7-H4 Is a Therapeutic Target for Aggressive Tumors.

Luana Guimaraes Sousa, Daniel J McGrail, Felippe Lazar Neto

Pageof 2